Bergamot for Heart Health: The Most Potent Natural LDL-Lowering Supplement
Bergamot is a citrus fruit native to Calabria, Italy, exceptionally rich in cholesterol-lowering flavonoids (neoeriocitrin, neohesperidin, naringin). Clinical studies using 1,000 mg daily show a 30.6% reduction in LDL, 37.9% reduction in triglycerides, and 40.1% increase in HDL. It also reduces visceral belly fat and slows carotid artery wall thickening. Best for patients with high LDL, high triglycerides, and excess belly fat who need robust lipid lowering without statins. Excellent safety profile — no significan’t side effects in clinical trials.
Key clinical numbers
Numbers from clinical studies using 1,000 mg standardized bergamot extract daily. Individual results vary based on baseline lipid levels and metabolic profile.
The evidence
Bergamot (Citrus bergamia) is a small citrus fruit grown almost exclusively in the Calabria region of southern Italy, where the unique soil and climate conditions produce an exceptionally high concentration of polyphenolic flavonoids. The primary active compounds — neoeriocitrin, neohesperidin, and naringin — are responsible for bergamot’s cardiovascular effects and are not found in meaningful concentrations in other citrus fruits.
Mechanism — AMPK activation and beyond: Bergamot works primarily by activating AMPK (AMP-activated protein kinase), a master metabolic switch in cells that directly reduces cholesterol and triglyceride synthesis in the liver. Unlike statins, which block a single step in the cholesterol production pathway, bergamot’s AMPK activation has broader metabolic effects — reducing both lipid production and improving glucose handling simultaneously. It also inhibits HMG-CoA reductase (the same enzyme statins target), providing a complementary mechanism.
Clinical trial results: Studies using 1,000 mg/day of standardized bergamot polyphenol extract have produced striking results. A landmark Italian RCT found a 30.6% reduction in total LDL, a 37.9% reduction in triglycerides, and a 40.1% increase in HDL cholesterol. These are among the largest lipid-lowering effects ever documented for a non-prescription supplement. In absolute terms, this translates to approximately 55 mg/dL LDL reduction and 75 mg/dL triglyceride reduction from baseline — numbers that rival low-to-moderate-dose statin therapy in some patient populations.
The visceral fat advantage: Beyond lipid panel improvements, bergamot has a documented ability to reduce visceral adiposity — the metabolically dangerous fat stored around internal organs in the abdominal cavity. Visceral fat is a primary driver of insulin resistance, systemic inflammation, and cardiovascular risk independent of cholesterol levels. Bergamot also reduces the proportion of small, dense LDL particles, which are more atherogenic (plaque-forming) than large, fluffy LDL particles even at the same total LDL concentration.
Carotid intima-media thickness (CIMT): Studies have shown measurable reductions in CIMT — the thickness of the carotid artery wall, a direct non-invasive marker of atherosclerosis progression — over just 6 months of bergamot supplementation. This is one of the strongest surrogate markers for cardiovascular risk reduction available in clinical research, and bergamot is one of very few supplements with CIMT data.
Dose, form & what to look for
500–1,500 mg per day of standardized bergamot polyphenol extract. The most robust clinical results come from 1,000 mg/day. Lower doses (500 mg) show benefit but with smaller effect sizes. Doses above 1,500 mg have not been studied for additional benefit.
Standardisation is critical: Bergamot products must be standardized to their polyphenol content — specifically the flavonoid fraction (neoeriocitrin, neohesperidin, naringin). Products without standardisation on the label cannot guarantee clinically meaningful concentrations of active compounds. Look for products standardized to at least 25–40% bergamot polyphenols.
Calabrian sourcing: The flavonoid profile of bergamot grown outside Calabria, Italy differs significantly from the fruit used in clinical trials. When possible, choose products that specify Calabrian bergamot extract or cite the specific polyphenol profile.
Timing: Bergamot can be taken with or without food. Some patients find taking it with a meal improves tolerance, though GI side effects are uncommon.
Third-party testing: As with all supplements, choose products with NSF, USP, or Informed Sport certification to ensure the stated dose is accurate and the product is free from contaminants.
Side effects & drug interactions
Of the major cardiovascular nutraceuticals, bergamot has the cleanest safety record. No significan’t adverse effects have been reported in clinical trials at doses up to 1,500 mg/day. It does not cause the muscle symptoms associated with statins, the GI upset sometimes seen with berberine, or the antiplatelet effects of aged garlic and nattokinase.
Statin combination: Bergamot can be safely combined with statin therapy and may allow lower effective statin doses in some patients. Several trials have specifically studied bergamot as a statin adjunct. Discuss with your cardiologist if you are considering this combination.
Bergamot is in the citrus family, and some patients ask whether it carries the same drug interaction risk as grapefruit. Grapefruit’s interactions are driven primarily by furanocoumarins (especially bergapten), which inhibit CYP3A4 in the gut wall. Standardized bergamot polyphenol extracts used in cardiovascular studies are processed to remove or minimize furanocoumarins. However, if you are on medications with known grapefruit interactions (many statins, calcium channel blockers, certain immunosuppressants), confirm with your physician or pharmacist that the specific bergamot product you are using is furanocoumarin-free.
Blood sugar: Bergamot’s AMPK activation has mild glucose-lowering effects. Patients on insulin or oral hypoglycemics should monitor glucose when starting bergamot. Pregnancy and breastfeeding: Insufficient safety data — avoid during pregnancy and breastfeeding.
How bergamot compares to berberine and aged garlic
Numbers represent averages from published clinical trials. Individual results vary.
Frequently asked questions
Does bergamot carry the same drug-interaction risk as grapefruit?+
Grapefruit’s interactions are driven by furanocoumarins, which inhibit CYP3A4 in the gut wall. Standardized bergamot polyphenol extracts used in cardiovascular studies are processed to remove or minimize furanocoumarins. If you take medications with known grapefruit interactions — many statins, calcium channel blockers, certain immunosuppressants — confirm with your physician or pharmacist that your specific product is furanocoumarin-free.
Can bergamot be combined with a statin?+
Yes. Bergamot can be safely combined with statin therapy and may allow lower effective statin doses in some patients; several trials have studied it specifically as a statin adjunct. Discuss the combination with your cardiologist.
How much bergamot should I take, and what should I look for?+
500–1,500 mg/day of standardized bergamot polyphenol extract, with the most robust results at 1,000 mg/day. Choose a product standardized to at least 25–40% bergamot polyphenols, ideally Calabrian-sourced and third-party tested (NSF, USP, or Informed Sport).
How does bergamot compare to berberine and aged garlic?+
For lipid lowering, bergamot produces the largest reductions of the three — roughly 55 mg/dL LDL and 75 mg/dL triglycerides at 1,000 mg/day, versus more modest effects from berberine and aged garlic. Berberine adds significan’t blood-sugar benefit; aged garlic modestly lowers blood pressure. Bergamot also has the cleanest safety profile of the three.
Is bergamot safe long-term?+
Bergamot has an excellent safety profile, with no significan’t adverse effects reported in clinical trials at doses up to 1,500 mg/day. As with any supplement affecting lipids and glucose, Dr. Druz reassesses with repeat bloodwork — typically a lipid panel at 3 months — to confirm response and guide ongoing use.
References
- Gliozzi M, et al. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol. Int J Cardiol. 2013;170(2):140–145.
- Mollace V, et al. Hypolipemic and hypoglycaemic activity of bergamot polyphenols. Fitoterapia. 2011;82(3):309–316.
This guide is for educational purposes only and does not constitute medical advice. Always consult a qualified physician before starting any supplement, particularly if you are taking anticoagulants, statins, or other cardiovascular medications.
Medically reviewed by Dr. Regina Druz, MD, MBA, FACC, FMCP-M — Board-Certified Integrative Cardiologist at Holistic Heart Centers, Roslyn, NY. Last reviewed: May 2026.
From the Shop
Related conditions
Related services
Related HeartWell Toolkits
Want personalized guidance?
Dr. Druz reviews supplementation in the context of your full cardiovascular profile and medications.